Artemis Medicare Q4 FY26 Earnings Call Transcript Released
Artemis Medicare reported FY26 consolidated revenue of ₹1,081 crore (up 15.4%) and PAT of ₹104 crore (up 26.2%). Q4 FY26 revenue grew 16.4% to ₹279 crore, with PAT up 32.1% to ₹30 crore. The company plans to expand bed capacity to 2,000 by 2029, with a new 300-bed hospital in Raipur opening in Q1 FY27 and a 650-bed facility in South Delhi by FY29. Fundraising of up to ₹700 crore is approved.
The announcement includes significant financial performance details, new facility launches, expansion plans, and fundraising initiatives, all of which are material to investors and the company's future trajectory.
The company reported strong year-on-year growth in revenue and profit after tax for both the full fiscal year and the fourth quarter. Expansion plans and capacity increases indicate a positive outlook.
Artemis Medicare Services Limited has released the transcript of its Earnings Conference Call held on May 11, 2026, to discuss the operational and financial performance for the fourth quarter and the full fiscal year 2026.
The company reported a strong performance for FY26, with consolidated revenue from operations reaching ₹1,081 crore, a 15.4% year-on-year growth. This growth was driven by core specialties like cardiology, oncology, and orthopaedics, alongside an improved payer mix and an increase in high-complexity procedures. The EBITDA for the year stood at ₹218 crore with a 20.2% margin, and profit after tax was ₹104 crore, a 26.2% increase year-on-year.
For Q4 FY26, consolidated revenue from operations was ₹279 crore, a 16.4% growth compared to the same quarter last year. EBITDA for the quarter was ₹59 crore with a 21.3% margin, and profit after tax was ₹30 crore, a 32.1% increase. The flagship Gurugram hospital maintained strong performance with an occupancy level of 64.6% and an average revenue per occupied bed of ₹84,571 for Q4, a 7.3% increase year-on-year.
Artemis Medicare received the Platinum Green Building certification, enabling the addition of 100 beds to its Gurugram facility. International patient numbers continued to grow, showing a 26.9% increase for the financial year, with demand from Africa and CIS regions in addition to the Middle East. The company is on track to commence operations for its 300-bed super specialty hospital in Raipur in Q1 FY27 and is advancing plans for a 650-bed facility in South Delhi, expected by FY29.
Expansion initiatives include increasing bed capacity to 2,000 beds by 2029. The company also has Board approval for fundraising up to ₹700 crore to support expansion efforts. Future EBITDA margins for the Gurugram facility are projected to be north of 20%, driven by high-end patient growth, improved consumption efficiency, and corporate cost allocation. The Raipur facility is expected to incur losses of ₹18-20 crore in FY27 but is anticipated to be offset by growth in other facilities. The company is also exploring adding 100 more beds in Gurugram once occupancy reaches 70%.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.